Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment TORONTO, ON / ACCESSWIRE / February 11, 2021 / Novamind Inc. (CSE:NM) ("Novamind"), a leading mental health company...
Recapitalisation Led by Sophisticated Life Sciences Investor - Apeiron Investment Group Ltd
Bionomics Limited (ASX: BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical stage biopharmaceutical company, today announced that it has entered into a Subscription Agreement, with Apeiron Investment...